Mechanism of Action of Ocrelizumab in Multiple Sclerosis
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 30
- Registration Number
- NCT03344094
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
- Conditions
- Chronic Myeloid LeukemiaMyelofibroses
- Interventions
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 18
- Registration Number
- NCT03326310
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Squamous Cell Carcinoma of the Head and Neck
- Interventions
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT03325465
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization
- Conditions
- Contrast-induced Nephropathy
- Interventions
- Other: Exposure to CBCIN risk score
- First Posted Date
- 2017-10-10
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 5
- Registration Number
- NCT03305874
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Feasibility of At-Home Handheld Spirometry
- Conditions
- COPD
- Interventions
- Device: SpiroPD
- First Posted Date
- 2017-09-15
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 8
- Registration Number
- NCT03284203
- Locations
- 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
Tau PET Imaging in Atypical Dementias
- Conditions
- Primary Progressive Aphasia With Suspected Alzheimer's Disease
- Interventions
- Device: PET
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 70
- Registration Number
- NCT03283449
- Locations
- 🇺🇸
University of Chicago - American School Building, Chicago, Illinois, United States
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
- Conditions
- CLLB-cell Non Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 20
- Registration Number
- NCT03283137
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling
- Conditions
- Kidney Stone
- Interventions
- Dietary Supplement: Sodium and Potassium CitrateDietary Supplement: Placebo
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 30
- Registration Number
- NCT03281928
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Parkinson's Disease in African American and Caucasian Patients
- Conditions
- Parkinson Disease
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 2033
- Registration Number
- NCT03279445
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Diet and Sleep Monitoring
- Conditions
- Diet ModificationSleep
- Interventions
- Other: Diet Quality
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 5
- Registration Number
- NCT03257137
- Locations
- 🇺🇸
Univeristy of Chicago, Chicago, Illinois, United States